Could stem cell 'Messages' help repair scarred livers?
NCT ID NCT07472270
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether tiny particles from umbilical cord stem cells, called extracellular vesicles, are safe for people with liver cirrhosis. Up to 12 adults with moderate to severe liver damage will receive increasing doses through an IV. The goal is to see if this approach can improve liver function without causing serious side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vinmec Research Institute of Stem Cell and Gene Technology
Hanoi, 100000, Vietnam
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- A new procedure may offer relief for Cirrhosis-Related fluid buildup
- Can liver damage predict how drugs behave?
- Better crystal ball for liver crisis: new scores put to the test
- Blood thinner may stop early cirrhosis from turning deadly — a major trial puts it to the test
- Stick-On ultrasound patch could spot liver damage without a specialist